Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe

David R. Coghill; Tobias Banaschewski; Peter Nagy; Isabel Hernández Otero; César Soutullo; Brian Yan; Beatriz Caballero; Alessandro Zuddas

doi:10.1007/s40263-017-0443-y

Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe

CNS Drugs ◽

10.1007/s40263-017-0443-y ◽

2017 ◽

Vol 31 (7) ◽

pp. 625-638 ◽

Cited By ~ 16

Author(s):

David R. Coghill ◽

Tobias Banaschewski ◽

Peter Nagy ◽

Isabel Hernández Otero ◽

César Soutullo ◽

...

Keyword(s):

Children And Adolescents ◽

Open Label ◽

Lisdexamfetamine Dimesylate ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Phase Iv

Download Full-text

Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study

International Journal of Geriatric Psychiatry ◽

10.1002/gps.859 ◽

2003 ◽

Vol 18 (6) ◽

pp. 549-551 ◽

Cited By ~ 42

Author(s):

V. P. Prasher ◽

C. Adams ◽

R. Holder ◽

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Down Syndrome ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text

Safety and Efficacy of 10 kHz Spinal Cord Stimulation for the Treatment of Refractory Chronic Migraine: A Prospective Long‐Term Open‐Label Study

Neuromodulation Technology at the Neural Interface ◽

10.1111/ner.13465 ◽

2021 ◽

Author(s):

Adnan Al‐Kaisy ◽

Stefano Palmisani ◽

Roy Carganillo ◽

Samuel Wesley ◽

David Pang ◽

...

Keyword(s):

Spinal Cord ◽

Chronic Migraine ◽

Spinal Cord Stimulation ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Refractory Chronic Migraine

Download Full-text

A long-term, open-label study of the safety and efficacy of oral tazarotene in moderate to very severe plaque psoriasis

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2003.10.012 ◽

2004 ◽

Vol 50 (3) ◽

pp. P2 ◽

Cited By ~ 1

Author(s):

Alan Menter ◽

Deborah Lew-Kaya ◽

Frederick Beddingfield ◽

Patricia S. Walker

Keyword(s):

Plaque Psoriasis ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Severe Plaque Psoriasis

Download Full-text

Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate

CNS Drugs ◽

10.1007/s40263-017-0487-z ◽

2018 ◽

Vol 32 (1) ◽

pp. 85-95 ◽

Cited By ~ 7

Author(s):

David R. Coghill ◽

Tobias Banaschewski ◽

Caleb Bliss ◽

Brigitte Robertson ◽

Alessandro Zuddas

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Cognitive Function ◽

Children And Adolescents ◽

Attention Deficit ◽

Open Label ◽

Lisdexamfetamine Dimesylate ◽

Open Label Study ◽

Label Study ◽

Hyperactivity Disorder

Download Full-text

Efficacy of long-term treatment with lurasidone in children and adolescents with bipolar depression: Interim analysis of a 2-year open-label study

European Neuropsychopharmacology ◽

10.1016/j.euroneuro.2018.11.564 ◽

2019 ◽

Vol 29 ◽

pp. S368

Author(s):

M.P. DelBello ◽

R. Goldman ◽

M. Tocco ◽

A. Pikalov ◽

L. Deng ◽

...

Keyword(s):

Children And Adolescents ◽

Interim Analysis ◽

Bipolar Depression ◽

Term Treatment ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Long Term Treatment

Download Full-text

Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

CNS Drugs ◽

10.1007/s40263-018-0514-8 ◽

2018 ◽

Vol 32 (5) ◽

pp. 455-467 ◽

Cited By ~ 6

Author(s):

Tobias Banaschewski ◽

Mats Johnson ◽

Peter Nagy ◽

Isabel Hernández Otero ◽

César A. Soutullo ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Open Label ◽

Lisdexamfetamine Dimesylate ◽

Open Label Study ◽

Label Study ◽

Hyperactivity Disorder

Download Full-text

Long-Term, Open-Label Study of the Safety and Efficacy of Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder

The Journal of Clinical Psychiatry ◽

10.4088/jcp.v66n0304 ◽

2005 ◽

Vol 66 (03) ◽

pp. 294-299 ◽

Cited By ~ 75

Author(s):

Lenard A. Adler ◽

Thomas J. Spencer ◽

Denái R. Milton ◽

Rodney J. Moore ◽

David Michelson

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Hyperactivity Disorder

Download Full-text

Long-term Safety and Efficacy of Vigabatrin in Japanese Patients with Infantile Spasms: A Multicenter Open-label Study

Journal of the Japan Epilepsy Society ◽

10.3805/jjes.36.17 ◽

2018 ◽

Vol 36 (1) ◽

pp. 17-31 ◽

Cited By ~ 1

Author(s):

Yoko Ohtsuka ◽

Masayuki Horiguchi

Keyword(s):

Japanese Patients ◽

Infantile Spasms ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text

Open‐Label Study of Long‐Term Safety and Efficacy of Intravenous Trappsol Cyclo (HPβCD) in Niemann‐Pick Disease Type C

Case Medical Research ◽

10.31525/ct1-nct03893071 ◽

2019 ◽

Author(s):

Keyword(s):

Disease Type ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Niemann Pick Disease ◽

Type C ◽

Niemann Pick ◽

Pick Disease

Download Full-text

Open-label Study to Evaluate Long-Term Safety and Efficacy of SPN-812 in Adults With ADHD

Case Medical Research ◽

10.31525/ct1-nct04143217 ◽

2019 ◽

Author(s):

Keyword(s):

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text